Search
Now showing items 1-10 of 60
Human rotavirus vaccine (Rotarix): focus on effectiveness and impact 6 years after first introduction in Africa
(Taylor & Francis, 2015)
A decade after licensure of the human rotavirus vaccine (HRV), a wealth of evidence supports a reduction of rotavirus (RV) gastroenteritis-associated mortality and hospitalizations following HRV inclusion in national ...
Rotavirus vaccines for the developing world
(Lippincott Williams, 2009)
The authors discuss the most relevant information in the field of rotavirus vaccines
published from October 2007 to June 2009; new information on the virus, host
response and disease burden that relate to our understanding ...
Rotavirus vaccines roll-out in resource-deprived regions
(Elsevier, 2015)
The Type of Growth Medium Affects the Presence of a Mycobacterial Capsule and Is Associated With Differences in Protective Efficacy of BCG Vaccination Against Mycobacterium tuberculosis
(2016)
Background. Bacillus Calmette-Guerin (BCG) vaccine is widely used for the prevention of tuberculosis, despite limited efficacy. Most immunological studies of BCG or Mycobacterium tuberculosis strains grow bacteria in the ...
Effectiveness of a proteoliposome‑based vaccine against salmonid rickettsial septicaemia in Oncorhynchus mykiss
(BMC, 2021)
Salmonid rickettsial septicaemia (SRS) is a contagious disease caused by Piscirickettsia salmonis, an intracellular bacterium.
SRS causes an estimated economic loss of $700 million USD to the Chilean industry annually. ...
Oral vaccination of Atlantic salmon (Salmo salar) against salmonid rickettsial septicaemia
(Elsevier, 2011)
Effective oral immunization systems may be very helpful to the salmon industry, particularly
during the seawater growth stages in which vaccination through injection is not possible. During
the seawater growing stage, ...
Efficacy, immunogenicity, and safety of a 9-valent human papillomavirus vaccine in latin american girls, boys, and young women
(Elsevier, 2018-06)
Background: A 9-valent human papillomavirus (HPV6/11/16/18/31/33/45/52/58; 9vHPV) vaccine was developed to expand coverage of the previously developed quadrivalent (HPV6/11/16/18; qHPV) vaccine.
Methods: Efficacy, ...
Rotarix®: Vaccine performance 6 years postlicensure
(2011)
Rotarix® was first licensed in 2004 and rapidly introduced into private and public markets worldwide. In a previous 2009 article, we reviewed the impact of rotavirus-associated disease, the rationale for different vaccines, ...
Potential cost effectiveness of a rotavirus vaccine in Chile Evaluación de costo-efectividad de la vacuna anti-rotavirus en Chile
(2006)
Background: Cost effectiveness studies are essential to assess the real value of interventions with preventive or therapeutic objectives. Aim: To assess the theoretical cost-effectiveness of a vaccine against rotavirus in ...
¿Es tiempo de vacunar a la mujer embarazada contra la coqueluche?
(Sociedad Chilena de Infectología, 2016)
Pertussis may cause death in neonates and very young infants. In these ages pertussis vaccine has not been
administered yet or infants haven’t received enough doses of vaccine to protect them. Cocoon strategy have ...